Novartis US Foundation COVID-19 Response

In response to the COVID-19 pandemic in the US, the Novartis US Foundation established a Response Fund, which will provide USD 5 million over a one-year period for immediate response and recovery efforts related to the pandemic. • Funding will support local initiatives and communities in the US impacted by the outbreak.  Initial grants will focus on immediate need for digital tools and frontline medical organization needs, including: $250,000 grant to the Commons Project for the development of COVIDcheck, a free public digital health service under development with global, national, state and local public health authorities; $125,000 grants to Americares and Direct Relief to support US safety net clinics.

Content from this campaign

Philanthropy

Novartis and the Novartis US Foundation Establish USD 5 Million US COVID-19 Community Response Fund
Novartis announced today, that in response to the COVID-19 pandemic in the US, Novartis and the Novartis US Foundation have established a US COVID-19 Community Response Fund.

More from Novartis

The Novartis Malaria Initiative

For over a decade, the Novartis Malaria Initiative has been a pioneer in the fight against malaria. Focused on access, treatment, R&D and capacity...

Novartis – science based innovation for better patient outcomes

Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.

Novartis Access: Medicines to treat chronic diseases in lower-income countries

Novartis recently announced the launch of the Novartis Access Portfolio, a first-of-its-kind portfolio approach in healthcare industry, aiming to...

Novartis Foundation Leprosy Elimination Initiative

The Novartis Foundation is convening experts from the global health and anti-leprosy community to discuss the current state of leprosy treatment and...

Novartis US Foundation commits $25M to improve health equity by reducing health disparities in the US

Building on $10M+ commitments to date, US Foundation is providing up to an additional $15M due to emergence of COVID-19 pandemic and elevated focus on...

Novartis US Foundation

Initiatives summarizing efforts from the Novartis US Foundation.

Novartis COVID-19 Trials

Novartis clinical trial efforts in COVID-19 R&D.

Novartis US Foundation COVID-19 Response

In response to the COVID-19 pandemic in the US, the Novartis US Foundation established a Response Fund, which will provide USD 5 million over a one...